Epidemiology and Control of Mansonella Perstans Infection in Uganda

DBL -Institute for Health Research and Development

Status: Completed

Conditions: Abdominal Pains; Mansonelliasis; Lymphoedema; Pruritus

Treatments: Drug: ivermectin and albendazole

Study type: Interventional

Funder types: Other

Identifiers

NCT00215280

MV917090205

Details and patient eligibility

About

Mansonella perstans (M. perstans) infection is widespread in Uganda. Knowledge about the epidemiology of this infection, and of the morbidity it induces is poor, and no effective treatment is available. The study aims at providing data on diagnostic, epidemiological, morbidity and treatment aspects of M. perstans infections in Uganda.

Full description

Overall objective: to investigate diagnostic, epidemiological and treatment aspects of M. perstans in Uganda with relevance to control

Specific objectives:

1. To establish the pattern of diurnal periodicity of M. perstans microfilaraemia in humans
2. To establish the patterns of M. perstans microfilaraemia and possible clinical manifestations related to this infection in two communities with medium to high endemicity
3. To determine the efficacy of ivermectin alone and the combination of ivermectin and albendazole on M. perstans microfilaraemia.

Sex: All

Ages: 5+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Individuals >= 5 years with or without M. perstans infection

Exclusion criteria

• Individuals < 5 years
• Pregnant women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind